To the best of our knowledge, this is the first study extensively exploring the possible therapeutic potential of targeting PRMT5 in MTAP‐deleted MM cells, also showing the effect of its silencing on the expression of genes implicated in MM growth and progression. The gene discussed is PRMT5; the disease is Miyoshi myopathy.